.
MergerLinks Header Logo

New Deal


Announced

Mérieux Equity Partners-backed Janvier Labs to acquire Yecuris.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

technology development

Acquisition

Pending

Biotechnology

United States

Cross Border

Majority

Private

Friendly

Single Bidder

Synopsis

Edit

Mérieux Equity Partners-backed Janvier Labs, a company specializing in biomedical research, agreed to acquire Yecuris, a start-up company based on technology developed in the laboratory of Dr. Markus Grompe at Oregon Health and Science University. Financial terms were not disclosed. “We are pleased to welcome Yecuris into the Janvier Group. With its know-how, Yecuris strengthens our in vivo and in vitro product offerings as well as our preclinical services offerings, which complements the scope of current capabilities of the Group. This integration implements our willingness to develop our presence in the international market, adding a Janvier Group site in the US. Yecuris strongly complements the other Janvier Group companies and will strengthen the Group’s attractiveness to our customers," Thomas Janvier, Janvier Group CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US